Mediolanum International Funds Ltd
Position in KRYS — Krystal Biotech, Inc.
CIK 2022028
DUBLIN 1, L2
Position in KRYS
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$5,924,419
New position
Shares Held
15,940
first reported quarter
Ownership
0.054%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#102
of 419 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mediolanum International Funds Ltd holds $75,305,474 across 10 Biotechnology names. KRYS ranks #5 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
29,785 | $27,633,629 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
46,396 | $13,966,587 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,754 | $9,199,709 | |
| 4 | INCY |
Incyte Corp
|
76,627 | $8,686,436 | |
| 5 | KRYS |
Krystal Biotech, Inc.
This page
|
15,940 | $5,924,419 | |
| 6 | ASND |
Ascendis Pharma A/S
|
11,697 | $3,119,823 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,776 | $2,869,112 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
28,940 | $2,358,899 |
All Filings in KRYS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,924,419 | 15,940 | Shares | Sole | 2026-07-23 | |
| No filing history on record for this holder in this stock. | ||||||